Inducing of insulin producing like cell with bone marrow-derived mesenchymal stem cell

China Biotechnology

2006, Vol. 26

Issue (0): 230-233 DOI:

Inducing of insulin producing like cell with bone marrow-derived mesenchymal stem cell

Download:

HTML

PDF(364KB) HTML
Export: BibTeX | EndNote (RIS)

Abstract

Diabetes mellitus is one of the heading causes of morbidity and mortality in many countries .It caused by an absolute insulin deficiency due to the destruction of insulin secreting pancreatic cells or by a relative insulin deficiency due to decreased insulin sensitivity, characterized with choronic hyperglycemia. Islet transplantation has been shown to restore normoglycemia ,but a limited supply and graft immune rejection prevents this therapy. Mesenchymal stem cells have the potency of differentiation into islet cells, it may act as a new source of islet transplantation in diabetes mellitus treatment.

Key words： bone marrow-derived mesenchymal stem cells diabetes mellitus islet transplantation

Received: 20 December 2005 Published: 15 June 2006

	Service
	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors

Cite this article:

. Inducing of insulin producing like cell with bone marrow-derived mesenchymal stem cell. China Biotechnology, 2006, 26(0): 230-233.

URL:

https://manu60.magtech.com.cn/biotech/ OR https://manu60.magtech.com.cn/biotech/Y2006/V26/I0/230

[1]	CHEN Fei,WANG Xiao-bing,XU Zeng-hui,QIAN Qi-jun. Molecular Mechanism and Clinical Research Progress of Mesenchymal Stem Cells in the Treatment of Diabetes Mellitus[J]. China Biotechnology, 2020, 40(7): 59-69.

[2]	Qiu-xia YAN,Yi MA,An HONG. Research Progress of Pituitary Adenylate Cyclase-activating Polypeptide (PACAP) as a New Potential Therapeutic Peptide in Diabetes and Its Complications[J]. China Biotechnology, 2018, 38(1): 62-68.

[3]	SUN Yi-ping, WANG Yue, JIN Zhen, WANG Xiao-yan, SUN Lei, ZHANG Xuan, FENG Chong, ZHOU Xiao-hua. *Establishment and Phenotype Analysis of SHBG* Knockout Mouse Model**[J]. China Biotechnology, 2017, 37(8): 39-45.

[4]	YUAN Feng-shan, WANG Chang-jun, DONG Fei, ZHAO Yu-hang. The Therapeutic Effect of the Induced Insulin Secreting Cells on Rat Diabetes[J]. China Biotechnology, 2011, 31(5): 94-98.

[5]	. The Therapeutic Effect of the Induced Insulin Secreting Cells on Rat Diabetes[J]. China Biotechnology, 2011, 31(05): 0-0.

[6]	LIU Yan-jie, JI Hong, LIN Lu-xia, ZANG Xue-zhang, SONG Chang-zheng, RONG Hai-qin. Solid Phase Peptide Synthesis and Analysis for Exendin-4[J]. China Biotechnology, 2011, 31(02): 69-73.

[7]	HE Lin-lin, LAN Fei, XUE Xiao-ping. Effects of Tumor Necrosis Factor-alpha on the Osteogenic Differentiation of Mouse Bone Marrow-derived Mesenchymal Stem Cells[J]. China Biotechnology, 2011, 31(01): 6-11.

[8]	SONG Wen-Cheng, JIN Meng-Fei, LI Dong-Jing, DIAO Li-Fen, ZHANG Hong-Dan, HUANG Jing, TUN Zi-Rong. Cloning, Expression, Purification and Its Biological Activity Study of a Novel GIP Analog[J]. China Biotechnology, 2010, 30(06): 38-43.

[9]	HONG Xiang- Ma-Meng-Gao- Feng-Shen- Tun-Xie-Lin- Zhang-Xu-Ying- Jin-Meng-Fei- Huang-Jing- Tun-Zi-Rong. Expression and Activity of Recombinant Human Glutamate Decarboxylase 65[J]. China Biotechnology, 2009, 29(04): 12-16.

[10]	. Glucagon-Like PeptideⅠand targeted differentiation of stem cells[J]. China Biotechnology, 2007, 27(4): 115-119.

[11]	. AOT/Isooctane reverse micellar extraction by adding ethanol Chen Lin-Jie, Cao Xue-Jun[J]. China Biotechnology, 2007, 27(1): 75-84.

Viewed

Full text

Abstract

Cited

Shared

Discussed